Explore ARDC

RAiD https://raid.org/10.82287/af38717d
Pipeline Accelerator - Voucher Scheme - 25-26 Round 2

Dates

Start Date
01-Mar-2026
End Date
30-Jun-2026

Titles

Title
Pipeline Accelerator - Voucher Scheme - 25-26 Round 2
Title Type
Primary
Title Type:
Primary
 Preferred full description or abstract.
Start Date
01-Mar-2026
End Date
30-Jun-2026
Language

Descriptions

No Entries

Contributors

Leader
Yes
Contact
Yes
Positions
Position
Principal or Chief Investigator
Position:
Principal or Chief Investigator
 Principal investigator refers to the person(s) in charge of a research project
Start Date
01-Mar-2026
End Date
---
Roles
No Entries

Organisations

Name
Phenomics Australia

Roles
Role
Lead Research Organisation
Role:
Lead Research Organisation
 The research organistion administratively responsible for the project; administering organisation
Start Date
2026-07-01
End Date
2026-12-31

RelatedObjects

Citation

Phenomics Australia. (2026). Generating a model of variations in female reproductive tract development using a new stem cell reporter line. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2026). Developing a human iPSC-derived alveolar coculture platform to model respiratory infection and regeneration. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2026). Identifying which processes activated by p53 are critical to prevent tumour development to supportthe design of novel cancer therapies. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2026). Validating the generalizability of artificial intelligence for in silico drug combination prediction. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2026). CRISPR-Engineered Motor Neuron Disease Cell Models to Enable Target Validation and Accelerate Therapeutic Translation. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2026). Targeting Cholesin to Control Viral Immunity. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2026). Generation of Humanised CYP21A2 Mouse Models to Enable Translational Genome Editing Therapies for Congenital Adrenal Hyperplasia. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2026). Patient-Derived Cortical Organoids to Decipher Disease Mechanisms and Therapeutic Response in SLC6A1-Related NDD. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2026). Understanding the genetic basis of Syntelencephaly. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2026). Transcriptomic and phenotypic screening of aged human microtissues to advance Alzheimer's disease therapeutics. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2026). Developing a Scalable Hydrogel Discovery Platform for 3D Cancer Modelling. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2026). In vivo functional characterisation of candidate pathogenic variants in ubiquitin proteasome components. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2026). Scalable Allogeneic Tregs Platform for autoimmune diseases. Phenomics Australia.
Type
Funding
Categories
Output

Alternate Identifier

No Entries

Alternate URLs

No Entries

Related RAiDs

No Entries

Access

Type
Open Access
Type:
Open Access
 Open access refers to a resource that is immediately and permanently online, and free for all on the Web, without financial and technical barriers.The resource is either stored in the repository or referenced to an external journal or trustworthy archive.
Language
Text
Embargo Expiry

Subjects

No Entries

Raw Data

{
  "access": {
    "type": {
      "id": "https://vocabularies.coar-repositories.org/access_rights/c_abf2/",
      "schemaUri": "https://vocabularies.coar-repositories.org/access_rights/"
    }
  },
  "alternateIdentifier": [],
  "alternateUrl": [],
  "contributor": [
    {
      "contact": true,
      "id": "https://orcid.org/0000-0002-5324-8398",
      "leader": true,
      "position": [
        {
          "id": "https://vocabulary.raid.org/contributor.position.schema/307",
          "schemaUri": "https://vocabulary.raid.org/contributor.position.schema/305",
          "startDate": "2026-03-01"
        }
      ],
      "role": [],
      "schemaUri": "https://orcid.org/",
      "status": "AUTHENTICATED",
      "orcidInfo": {
        "orcidId": "0000-0002-5324-8398",
        "displayName": "Michael Dobbie",
        "nameType": "constructed",
        "visibility": "public",
        "authenticated": true,
        "claimed": true,
        "verified": false,
        "profileUrl": "https://orcid.org/0000-0002-5324-8398",
        "style": "underline"
      }
    }
  ],
  "date": {
    "endDate": "2026-06-30",
    "startDate": "2026-03-01"
  },
  "description": [],
  "identifier": {
    "id": "https://raid.org/10.82287/af38717d",
    "license": "Creative Commons CC-0",
    "owner": {
      "id": "https://ror.org/0201hm243",
      "schemaUri": "https://ror.org/",
      "servicePoint": 20000016,
      "servicePointName": "PhenomicsAus"
    },
    "raidAgencyUrl": "https://static.prod.raid.org.au/raids/10.82287/af38717d",
    "registrationAgency": {
      "id": "https://ror.org/038sjwq14",
      "schemaUri": "https://ror.org/"
    },
    "schemaUri": "https://raid.org/",
    "version": 3
  },
  "metadata": {
    "created": 1780464811,
    "updated": 1781497312
  },
  "organisation": [
    {
      "id": "https://ror.org/0201hm243",
      "role": [
        {
          "endDate": "2026-12-31",
          "id": "https://vocabulary.raid.org/organisation.role.schema/182",
          "schemaUri": "https://vocabulary.raid.org/organisation.role.schema/359",
          "startDate": "2026-07-01"
        }
      ],
      "schemaUri": "https://ror.org/",
      "rorDetails": {
        "rorId": "0201hm243",
        "name": "Phenomics Australia",
        "type": "Organization",
        "rorUrl": "https://ror.org/0201hm243"
      }
    }
  ],
  "relatedObject": [
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/p4dg-6s42",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2026). <i>Generating a model of variations in female reproductive tract development using a new stem cell reporter line</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/tpwr-xd91",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2026). <i>Developing a human iPSC-derived alveolar coculture platform to model respiratory infection and regeneration</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/t5na-pp22",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2026). <i>Identifying which processes activated by p53 are critical to prevent tumour development to supportthe design of novel cancer therapies</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/zb4b-z588",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2026). <i>Validating the generalizability of artificial intelligence for in silico drug combination prediction</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/j230-aq79",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2026). <i>CRISPR-Engineered Motor Neuron Disease Cell Models to Enable Target Validation and Accelerate Therapeutic Translation</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/k9b3-5d27",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2026). <i>Targeting Cholesin to Control Viral Immunity</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/wq77-9y82",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2026). <i>Generation of Humanised CYP21A2 Mouse Models to Enable Translational Genome Editing Therapies for Congenital Adrenal Hyperplasia</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/gwzw-ct60",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2026). <i>Patient-Derived Cortical Organoids to Decipher Disease Mechanisms and Therapeutic Response in SLC6A1-Related NDD</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/g39d-8w93",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2026). <i>Understanding the genetic basis of Syntelencephaly</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/9pwg-6v56",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2026). <i>Transcriptomic and phenotypic screening of aged human microtissues to advance Alzheimer's disease therapeutics</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/5dkz-5d35",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2026). <i>Developing a Scalable Hydrogel Discovery Platform for 3D Cancer Modelling</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/v601-kj52",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2026). <i>In vivo functional characterisation of candidate pathogenic variants in ubiquitin proteasome components</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/hcb0-6002",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2026). <i>Scalable Allogeneic Tregs Platform for autoimmune diseases</i>. Phenomics Australia."
      }
    }
  ],
  "relatedRaid": [],
  "spatialCoverage": [],
  "subject": [],
  "title": [
    {
      "endDate": "2026-06-30",
      "startDate": "2026-03-01",
      "text": "Pipeline Accelerator - Voucher Scheme - 25-26 Round 2",
      "type": {
        "id": "https://vocabulary.raid.org/title.type.schema/5",
        "schemaUri": "https://vocabulary.raid.org/title.type.schema/376"
      }
    }
  ]
}

Page generated: